Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Tuesday, September 29

2:15 PM - 2:25 PM ET

280 - Connectome-Informed Cognition-Sparing Stereotactic Brain Radiosurgery: Comparison of Cognitive Outcomes to Historical Controls
Speaker: Puett, Andrew, MD, PhD - UC San Diego Radiation Medicine and Applied Sciences, La Jolla, CA
2:15 PM - 2:25 PM ET

286 - First Implementation of an All-In-One Solution with Fully Automatic Workflow for Rectal Cancer Based on an Integrated CT-Linac
Speaker: Wang, Luqi - Peking University Third Hospital, Beijing
2:15 PM - 2:25 PM ET

292 - A Randomized, Phase II Clinical Trial of Stereotactic Body Radiation Therapy Or Conventionally Fractionated Concurrent Chemotherapy and Radiation Therapy Preoperatively for Pancreatic Adenocarcinoma, the SOFT Preop Study
Speaker: Hall, William, MD - Medical College of Wisconsin, Milwaukee, WI
2:15 PM - 2:25 PM ET

298 - Type I IFN Drives ILC2 to ILC1 Plasticity in Radiation-Induced Lung Injury
Speaker: Kim, Jaeho, MD - City of Hope, Glendale, CA
2:15 PM - 2:25 PM ET

304 - Glioblastoma Distant Recurrences Preferentially Occur Along White Matter Tracts Mapped Using Probabilistic Diffusion Tractography
Speaker: Gui, Chengcheng, MD - Johns Hopkins University School of Medicine, Baltimore, MD
2:15 PM - 2:25 PM ET

335 - AI as a Safety Net: Clinical and Dosimetric Impact of Intercepting Undetected Brain Metastases in SRS/SRT
Speaker: Kinz, Marvin, MS - Brigham and Women's Hospital/Dana Farber Cancer Institute, Boston, MA
2:15 PM - 2:25 PM ET

LBA 01 - TRIDENT: Phase 3 Trial of Tumor Treating Fields (TTFields) Therapy Concurrent with Temozolomide (TMZ) Radiochemotherapy Followed by Maintenance TMZ and TTFields for Newly Diagnosed Glioblastoma (ndGBM)
Speaker: Shi, Wenyin, MD, PhD - Thomas Jefferson University, Philadelphia, PA
2:25 PM - 2:35 PM ET

281 - Upfront Local Therapy in Melanoma Brain Metastases Treated with Ipilimumab-Nivolumab: An International Multicenter Analysis of Immunotherapy-Naïve Patients
Speaker: Lee, James - Memorial Sloan Kettering Cancer Center, Middletown Township, NJ
2:25 PM - 2:35 PM ET

287 - Personalizing PSA Follow-Up after Prostate Radiation Therapy: Developing a Patient Specific AI Powered Predictive Model for Clinically Meaningful Recurrence
Speaker: Borras-Osorio, Mariana - Department of Radiation Oncology, Mayo Clinic, Rochester, MN
2:25 PM - 2:35 PM ET

293 - Primary and Retrospective Analysis of GRECO-2: A Randomized, Double-Blind, Placebo-Controlled Phase II Trial of SABR ± Rucosopasem in Localized Pancreatic Cancer
Speaker: Aguilera, Todd, MD, PhD - UT Southwestern Medical Center, Dallas, TX
2:25 PM - 2:35 PM ET

299 - Radiotherapy Reshapes the Tumor Immune Microenvironment through PD-L1<sup>+</sup> Macrophages and Enhances Immunotherapy Efficacy in pMMR Colorectal Cancer
Speaker: He, Luoxi - Fudan University Shanghai Cancer Center, Shanghai, Shanghai
2:25 PM - 2:35 PM ET

305 - Identification of Conserved Recovery Phenotypes in Liver Re-Irradiation: A Longitudinal Study Using <sup>99m</sup>Tc-Sulfur Colloid SPECT/CT
Speaker: Kim, Yejin, PhD - University of Washington School of Medicine, Seattle, WA